Powered by the Consumer Technology Association (CTA)®

LAST CHANCE: Register before December 5 to save $200 on your CES 2025 registration!

Skip to content
2025 Honoree Award

Early Cancer Screening Device in Pets

Point Biotech
  • 2025 Honoree in Digital Health
The incidence of malignant lymphoma in companion dogs is up to 5 times higher than in humans,
so detection of early tumors is very critical for the successful tumor treatment.
Optical imaging can be used for tumor detection, but conventional optical imaging systems can detect tumors in only a dark room.
To tackle these technological limitations,
we've developed not only a cancer-targeting contrast agent but also an optical imaging technology that visualizes only tumors with high contrast even under the ambient light.
We have confirmed the excellence of high-resolution imaging devices through animal testing with researchers at Harvard Medical School.

Learn More About Digital Health at CES

Explore the latest advancements in AI, IoT, telehealth, and digital health solutions. These groundbreaking technologies are reshaping healthcare delivery, improving patient outcomes, and enhancing operational efficiency.

Alt text: A Man with short dark hair in a white lab coat stands confidently against a vibrant, abstract background with flowing shapes in blue, purple, green and white.

See More Innovation Awards